Associated Papers
Prevalence of synonymous mutations in m6A modification sites in human cancers.
Chen R et al.
Genes & Diseases, 2025
39524540 (PubMed )
Supplement: mmc3.xlsx › cosmic_GRCH38_DRACH_mutA_overla
Development and validation of a targeted gene sequencing panel for application to disparate cancers.
McCabe MJ et al.
Scientific Reports, 2019
31745186 (PubMed )
Supplement: 41598_2019_52000_MOESM2_ESM.xlsx › Sheet1
Validation of the Oncomine™ focus panel for next-generation sequencing of clinical tumour samples.
Williams HL et al.
Virchows Archiv : an International Journal of Pathology, 2018
30105577 (PubMed )
Supplement: 428_2018_2411_MOESM1_ESM.xlsx › REF4
Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer.
Ashktorab H et al.
Oncotarget, 2017
28002797 (PubMed )
Supplement: oncotarget-08-7852-s002.xlsx › BRAF.Ion
Mobile Genome Express (MGE): A comprehensive automatic genetic analyses pipeline with a mobile device.
Yoon JH et al.
Plos One, 2017
RKIP and BRAF aberrations in human nasal polyps and the adjacent turbinate mucosae.
Zaravinos A et al.
Cancer Letters, 2008
BRAF gene is not mutated in mismatch repair-proficient or -deficient plasma cell dyscrasias.
Velangi M et al.
Leukemia, 2004
Select a paper to view details